These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 6184506

  • 1. Characterization of serum protein components from Donryu rats which were immune to hepatoma AH-66 tumor cells.
    Wepsic HT, Tsukada Y, Kobayashi K, Hara A, Hirai H.
    Jpn J Exp Med; 1982 Aug; 52(4):163-71. PubMed ID: 6184506
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM, Craddock GR, Warr GW, DeLuca D, Marchalonis JJ.
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.
    Cancer; 2002 Jan 15; 94(2):406-14. PubMed ID: 11900226
    [Abstract] [Full Text] [Related]

  • 7. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun 15; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y, Sendo F, Miyake T, Kobayashi H.
    J Natl Cancer Inst; 1981 Apr 15; 66(4):659-65. PubMed ID: 6939913
    [Abstract] [Full Text] [Related]

  • 14. [Detection and identification of the tumor-associated antigens in the fraction enriched with plasma membranes of the Zajdela hepatoma cells].
    Teriukov NP, Mirgorodskaia OA, Serebriakova MV, Ivanov VA.
    Tsitologiia; 2010 Apr 15; 52(10):827-34. PubMed ID: 21268838
    [Abstract] [Full Text] [Related]

  • 15. Distribution of Novikoff ascites hepatoma antigens p39 and p49 in various tumorigenic cell lines.
    Schmidt WN, Hnilica LS.
    Cancer Res; 1982 Apr 15; 42(4):1441-5. PubMed ID: 7060017
    [Abstract] [Full Text] [Related]

  • 16. Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.
    Shu S, Steerenberg PA, Hunter JT, Evans CH, Rapp HJ.
    Cancer Res; 1981 Sep 15; 41(9 Pt 1):3499-506. PubMed ID: 7260913
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
    Mizushima Y, Sendo F, Takeichi N, Hosohawa M, Kobayashi H.
    Cancer Res; 1981 Jul 15; 41(7):2917-21. PubMed ID: 6454480
    [Abstract] [Full Text] [Related]

  • 18. Effect of horse antibody to rat alpha-fetoprotein upon the growth of AH-66 in Donryu rats.
    Wepsic HT, Tsukada Y, Takeichi N, Nishi S, Hirai H.
    Int J Cancer; 1980 May 15; 25(5):655-61. PubMed ID: 6154665
    [Abstract] [Full Text] [Related]

  • 19. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC, Hank JA, Gan J, Sondel PM.
    Cell Immunol; 1996 Jan 10; 167(1):99-107. PubMed ID: 8548851
    [Abstract] [Full Text] [Related]

  • 20. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.